Chinook Therapeutics Closes Merger with Aduro Biotech and Completes $115 Million Private Placement Financing
Combined Company Will H ave Over $275 Million in Operating Capital and Trade on Nasdaq under the Ticker Symbol “KDNY”
Aduro Biotech Stockholders Approve Merger Agreement with Chinook Therapeutics
One-for-Five Reverse Stock Split to be Effective October 2, 2020